ECM Weekly (14 Apr 2025) - Suzuki, EBOS, Hengrui Pharma, Zenergy, Chagee, LG India, Huge Dental
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
961 Views
China Healthcare (Apr.13) - Trump's Tariffs on Pharmaceuticals, NSCEB's Report, RemeGen's Pain Point
āTrump's tariff on pharmaceuticals will impact Chinese companies.WuXi AppTec named in NSCEB report.China CXO's performance will be affected....
824 Views
Hengrui (ęēå»čÆ) A/H Listing: An Updated Comparison with Hansoh
Jiangsu Hengrui Medicine aims to raise around US$2bn in its H-share listing. In this note we provided an updated comparison with its close peer...
544 Views
Wuxi XDC Placement - Following Biologics Playbook, past Deals Have Been Mixed
WuXi AppTec (2359 HK) aims to raise around US$250m via selling around 3.5% stake in WuXi XDC Cayman (2268 HK). In this note, we talk about the deal...
454 Views
DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational
āDeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...
323 Views